Skip to main content
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1982 Nov 1;127(9):857–859.

Salbutamol: comparison of bronchodilating effect of inhaled powder and aerosol in asthmatic subjects.

K M Latimer, R Roberts, J Dolovich, F E Hargreave
PMCID: PMC1862216  PMID: 7139504

Abstract

In the treatment of asthma salbutamol can be administered as an aerosol with a metered-dose inhaler or as a powder with a breath-actuated device (Rotahaler). The two forms of the drug were compared in a double-blind placebo-controlled study involving 10 asthmatic adults who were known to respond to salbutamol. The bronchodilating effect of the aerosol and the powder at doses of 200 micrograms and of the powder at doses of 200 and 400 micrograms was compared, bronchodilation being measured in terms of forced expiratory volume and vital capacity. The response was far greater to salbutamol than to placebo, but there was no significant difference between the two forms of the drug or between the lower and higher doses of powder. No side effects were observed.

Full text

PDF
857

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Dolovich J., Hargreave F. E., Wilson W. M., Greenbaum J., Powles A. C., Newhouse M. T. Control of asthma. Can Med Assoc J. 1982 Mar 15;126(6):613–618. [PMC free article] [PubMed] [Google Scholar]
  2. Dolovich M., Ruffin R. E., Roberts R., Newhouse M. T. Optimal delivery of aerosols from metered dose inhalers. Chest. 1981 Dec;80(6 Suppl):911–915. [PubMed] [Google Scholar]
  3. Duncan D., Carmichael J., Crompton G. K. Salbutamol in the treatment of asthma. Practitioner. 1979 Dec;223(1338):843–844. [PubMed] [Google Scholar]
  4. Epstein S. W., Manning C. P., Ashley M. J., Corey P. N. Survey of the clinical use of pressurized aerosol inhalers. Can Med Assoc J. 1979 Apr 7;120(7):813–816. [PMC free article] [PubMed] [Google Scholar]
  5. Hetzel M. R., Clark T. J. Comparison of salbutamol Rotahaler with conventional pressurized aerosol. Clin Allergy. 1977 Nov;7(6):563–568. doi: 10.1111/j.1365-2222.1977.tb01486.x. [DOI] [PubMed] [Google Scholar]
  6. Morris J. F., Koski A., Johnson L. C. Spirometric standards for healthy nonsmoking adults. Am Rev Respir Dis. 1971 Jan;103(1):57–67. doi: 10.1164/arrd.1971.103.1.57. [DOI] [PubMed] [Google Scholar]
  7. Newman S. P., Pavia D., Clarke S. W. Simple instructions for using pressurized aerosol bronchodilators. J R Soc Med. 1980 Nov;73(11):776–779. doi: 10.1177/014107688007301105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Ruffin R. E., Obminski G., Newhouse M. T. Aerosol salbutamol administration by IPPB: lowest effective dose. Thorax. 1978 Dec;33(6):689–693. doi: 10.1136/thx.33.6.689. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Woolcock A. J. Inhaled drugs in the prevention of asthma. Am Rev Respir Dis. 1977 Feb;115(2):191–194. doi: 10.1164/arrd.1977.115.2.191. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES